362 related articles for article (PubMed ID: 31803695)
21. Frontline treatment of acute myeloid leukemia in adults.
Tamamyan G; Kadia T; Ravandi F; Borthakur G; Cortes J; Jabbour E; Daver N; Ohanian M; Kantarjian H; Konopleva M
Crit Rev Oncol Hematol; 2017 Feb; 110():20-34. PubMed ID: 28109402
[TBL] [Abstract][Full Text] [Related]
22. Current and emerging therapies for acute myeloid leukemia.
Robak T; Wierzbowska A
Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
[TBL] [Abstract][Full Text] [Related]
23. [Novel therapies for pediatric acute myeloid leukemia: building future strategies through incorporation of treatment currently used in adults].
Moritake H
Rinsho Ketsueki; 2020; 61(6):665-672. PubMed ID: 32624541
[TBL] [Abstract][Full Text] [Related]
24. [Clinical characteristics and prognosis of 34 cases of acute myeloid leukemia with FLT3 internal tandem duplication and MLL gene rearrangement].
Zhou JR; Zhang X; Zhao YL; Yang JF; Zhang JP; Cao XY; Lu Y; Liu DY; Lyu FY; Ouyang J; Lu PH
Zhonghua Xue Ye Xue Za Zhi; 2018 Sep; 39(9):751-756. PubMed ID: 30369187
[No Abstract] [Full Text] [Related]
25. Midostaurin/PKC412 for the treatment of newly diagnosed FLT3 mutation-positive acute myeloid leukemia.
Luskin MR; DeAngelo DJ
Expert Rev Hematol; 2017 Dec; 10(12):1033-1045. PubMed ID: 29069942
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
27. Pediatric AML: From Biology to Clinical Management.
de Rooij JD; Zwaan CM; van den Heuvel-Eibrink M
J Clin Med; 2015 Jan; 4(1):127-49. PubMed ID: 26237023
[TBL] [Abstract][Full Text] [Related]
28. [Novel therapies for acute myeloid leukemia based on genomic aberrations].
Umezawa Y; Kawamata N
Rinsho Ketsueki; 2019; 60(6):594-599. PubMed ID: 31281150
[TBL] [Abstract][Full Text] [Related]
29. Recent advances in pediatric acute lymphoblastic and myeloid leukemia.
Ravindranath Y
Curr Opin Oncol; 2003 Jan; 15(1):23-35. PubMed ID: 12490758
[TBL] [Abstract][Full Text] [Related]
30. [Acute leukemia in adults].
Eigendorff E; Hochhaus A
Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
[TBL] [Abstract][Full Text] [Related]
31. New targets in pediatric Acute Myeloid Leukemia.
Miano M; Micalizzi C; Calvillo M; Dufour C
Immunol Lett; 2013; 155(1-2):47-50. PubMed ID: 24113357
[TBL] [Abstract][Full Text] [Related]
32. From Bench to Bedside and Beyond: Therapeutic Scenario in Acute Myeloid Leukemia.
Gurnari C; Voso MT; Maciejewski JP; Visconte V
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32033196
[TBL] [Abstract][Full Text] [Related]
33. The Time Has Come for Targeted Therapies for AML: Lights and Shadows.
Fiorentini A; Capelli D; Saraceni F; Menotti D; Poloni A; Olivieri A
Oncol Ther; 2020 Jun; 8(1):13-32. PubMed ID: 32700072
[TBL] [Abstract][Full Text] [Related]
34. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
35. Unmet clinical needs and economic burden of disease in the treatment landscape of acute myeloid leukemia.
Wiese M; Daver N
Am J Manag Care; 2018 Aug; 24(16 Suppl):S347-S355. PubMed ID: 30132678
[TBL] [Abstract][Full Text] [Related]
36. Dual FLT3 inhibitors: Against the drug resistance of acute myeloid leukemia in recent decade.
Yuan T; Qi B; Jiang Z; Dong W; Zhong L; Bai L; Tong R; Yu J; Shi J
Eur J Med Chem; 2019 Sep; 178():468-483. PubMed ID: 31207462
[TBL] [Abstract][Full Text] [Related]
37. Quizartinib (AC220): a promising option for acute myeloid leukemia.
Zhou F; Ge Z; Chen B
Drug Des Devel Ther; 2019; 13():1117-1125. PubMed ID: 31114157
[TBL] [Abstract][Full Text] [Related]
38. Acute Myeloid Leukemia: Diagnosis and Management Based on Current Molecular Genetics Approach.
Suguna E; Farhana R; Kanimozhi E; Kumar PS; Kumaramanickavel G; Kumar CS
Cardiovasc Hematol Disord Drug Targets; 2018; 18(3):199-207. PubMed ID: 29766829
[TBL] [Abstract][Full Text] [Related]
39. Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches.
Winer ES; Stone RM
Ther Adv Hematol; 2019; 10():2040620719860645. PubMed ID: 31321011
[TBL] [Abstract][Full Text] [Related]
40. Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy.
Weisberg E; Sattler M; Manley PW; Griffin JD
Onco Targets Ther; 2018; 11():175-182. PubMed ID: 29343975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
